Tribasic calcium phosphate

Get a Price/Quote

MOQ : 1 Kilograms

Tribasic calcium phosphate Specification

Molecular Weight
310.18 Grams (g)

Usage
It may be used to treat conditions caused by low calcium levels such as bone loss (osteoporosis), weak bones (osteomalacia/rickets), decreased activity of the parathyroid gland (hypoparathyroidism), and a certain muscle disease (latent tetany).

Melting Point
1670 K (1391 °C)

Appearance
White amorphous powder

Molecular Formula
Ca3(PO4)2

Physical Form
Powder

Tribasic calcium phosphate Trade Information

Minimum Order Quantity
1 Kilograms

Payment Terms
Cash in Advance (CID), Cash Advance (CA)

Supply Ability
500 Kilograms KG Per Month

Delivery Time
2-8 Week

Sample Available
Yes

Sample Policy
Sample costs shipping and taxes has to be paid by the buyer

Packaging Details
Carton and Poly Bag.

Main Export Market(s)
Western Europe, Middle East, Africa, Central America, Eastern Europe, South America, Asia, North America, Australia

Main Domestic Market
All India

About Tribasic calcium phosphate

Tribasic calcium phosphate Synonym: Calcium hydroxyphosphate, Calcium phosphate tribasic, HAp, Hydroxylapatite, Tribasic calcium phosphate Linear Formula: [Ca5(OH)(PO4)3]xMolecular Weight: 502.31CAS Number: 12167-74-7

FAQs of Tribasic calcium phosphate:

Q: What is the physical form of Tribasic Calcium Phosphate?

A: The physical form of Tribasic Calcium Phosphate is powder.

Q: What is the melting point of Tribasic Calcium Phosphate?

A: The melting point of Tribasic Calcium Phosphate is 1670 K (1391 C).

Q: What is the molecular formula of Tribasic Calcium Phosphate?

A: The molecular formula of Tribasic Calcium Phosphate is Ca3(PO4)2.

Q: What does Tribasic Calcium Phosphate look like?

A: Tribasic Calcium Phosphate appears as a white amorphous powder.

Q: What is the primary usage of Tribasic Calcium Phosphate?

A: Tribasic Calcium Phosphate may be used to treat conditions caused by low calcium levels, such as bone loss (osteoporosis), weak bones (osteomalacia/rickets), decreased activity of the parathyroid gland (hypoparathyroidism), and a muscle disease called latent tetany.